Fish Oil Omega-3 Fatty Acid Research


Scientific research supporting the claim that Omega-3 Fatty Acids help Support a Healthy Brain.

Fish Oil Home


Gamoh, S., M. Hashimoto, K. Sugioka, S. Hossain, N. Hata, Y. Misawa, and S. Masumura. "Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats." Neurosci 93:237-241 (1999).

Jones, C. R., T. Aria, and S. I. Rapoport. "Evidence for the involvement of docosahexaenoic acid in cholinergic simulated signal transduction at the synapse." J Neurochem Res 22:663-670 (1997).

Katzman, R., and J. E. Jackson. "Alzheimer disease: Basic and clinical advances." J Am Geriatrics Soc 39:516-525 (1991).

Kodas E., Page G., Zimmer L., Vancassel S., Guilloteau D., Durand G., Chalon S. "Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents.” Neurosci Lett 321(1-2):95-9 (2002).

Kyle, D. J., E. Schaefer, G. Patton, and A. Beiser. "Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia." Lipids 34:S245 (1999).

Lauritzen, I., N. Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski. "Polyunsaturated fatty acids are potent neuroprotectors." EMBO J 19:1784-1793 (2000).


Burgress, J. R., L. Stevens, and L. Peck. "Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder." Am J Clin Nutr 71:327S-330S (2000).

Connor, W. E., M. Neuringer, and D. S. Lin. "Dietary effects on brain fatty acid composition: The reversibility of n-3 fatty acids deficiency and turnover of docosahexaenoic acid in the brain erythrocytes and plasma of rhesus monkeys." J Lipid Res 31:237-247 (1990).

Connor, W. E., M. Neuringer, and S. Reisbick. "Essential fatty acids: Importance of n-3 fatty acids in the retina and brain." Ntr Rev 50:21-29 (1992).

Conquer, J. A., M. C. Tierney, J. Zecevic, W.J. Bettger, and R.H. Fisher. "Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment." Lipids 35:1305-1312 (2000).

Fenton W. ., Dickerson F., Boronow J., Hibbeln J. R., Knable M. “A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.” Am J Psychiatry 158(12):2071-4 (2001).
Lauritzen, L., H. S. Hansen, M. H. Jorgensen, and K. F. Michaelsen. "The essentiality of long-chain n-3 fatty acids in relation to development and function of the brain and retina." Prog Lipid Res 40:1-94 (2001).

Marangell L B, Martinez J M, Zboyan H A, Kertz B, Kim H F, Puryear L J. “A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.” Mood Disorders Center, Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.

Schiefermeier M., Yavin E. “n-3 Deficient and docosahexaenoic acid-enriched diets during critical periods of the developing prenatal rat brain.” J Lipid Res 43(1):124-31 (2002).

Sonderberg, M., C. Edlund, K. Kristensson, and G. Dallner. "Fatty acid composition of brain phospholipids in aging and Alzheimer's disease." Lipids 26:421-423 (1991).

Stevens, L. J., and J. Burgess. "Omega-3 fatty acids in boys with behavior, learning, and health problems." Physiol Behav 59:915-920 (1996).
Voigt, R. G., A. M. Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta, and W. C. Heird. "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder." J Pediatr 139:189-196 (2001).

Vance, H. E., R. B. Campenot, and D. E. Vance. "The synthesis and transport of lipids for axonal growth and nerve regeneration." Biochim Biophys Acta 1486:84-96 (2000).

Yeh, Y. Y., M. F. Gehman, and S. M. Yeh. "Maternal dietary fish oil enriches docosahexaenoate levels in brain subcellular fractions of offspring." J Neurosci Res 35:218-226 (1993).

Yehuda, S., S. Rabinovitz, R.L. Carasso, and D.I. Mostofsky. "Essential fatty acid preparation improves Alzheimer's patients' quality of life." Int J Neurosci 87:141-149 (1996).

Willatts, P., J. S. Forsyth, M. K. DiModugno, S. Varma, and M. Colvin. “Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age.” Lancet 352:688-691 (1998).
Stevens, L. J., S. S. Zentall, J. L. Deck, M. L. Abate, B. A. Watkins, S. A. Lipp, and J. R. Burgess. "Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder." Am J Clin Nutr 62:761-768 (1995).

Stordy, B. J. "Benefit of docosahexaenoic acid supplements to dark adaption in dyslexics." Lancet 346:385 (1995).

Terano, T., S. Fujishiro, T. Ban, K. Yamamoto, T. Tanaka, Y. Noguchi, Y. Tamura, K. Yazawa, and T. Hirayama. "Docosahexaenoic acid supplementation improves moderately severe dementia from thromboitc cerebrovascular diseases. Lipids 34:S345-S346 (1999).

 

 

** These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. You should consult your doctor before taking any supplements, or changing your diet. Site layout and graphics copyright 2006 - You may not copy or reproduce this webpage without written authorization.